menu search

Dyne therapeutics to present new preclinical data at asgct annual meeting demonstrating force™ platform delivery to cns

- FORCE Delivers to CNS in Non-Human Primates - - FORCE Achieves Robust Reduction of Toxic Nuclear DMPK RNA and Foci in Brain of a DM1 Disease Model -...

May 2, 2023, 4:46 pm

2seventy bio to present new preclinical and clinical data from broad portfolio of investigational cell therapies at the asgct 26th annual meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced the presentation...

May 2, 2023, 4:37 pm

Cabaletta bio to present at the american society of gene and cell therapy 26th annual meeting

PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and la...

May 2, 2023, 4:35 pm

Taysha gene therapies announces presentation on new preclinical data for tsha-102 in rett syndrome at upcoming american society of gene and cell therapy 26th annual meeting

DALLAS, April 27, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing an...

April 27, 2023, 8:52 pm

Arbutus provides ab-729 clinical data and ab-161 preclinical data as oral presentations at the global hepatitis summit 2023

Seven patients with cHBV remain off all treatment and continue to maintain low levels of HBV DNA and HBsAg for at least one and half years post- AB-72...

April 27, 2023, 7:20 am

Uvax bio announces publication of results from preclinical studies of hiv vaccine candidates

Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategies Phase 1 clinical trial sponso...

April 26, 2023, 11:30 am

Betterlife to present betr-001 preclinical data at the 2023 annual meeting of the society of biological psychiatry (sobp) in san diego, california

VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BE...

April 25, 2023, 8:00 am

Vyne gains on preclinical data for ipf candidate

VYNE gains on positive preclinical data evaluating VYN201 for treating idiopathic pulmonary fibrosis....

April 20, 2023, 12:57 pm

Sensei biotherapeutics presents new preclinical data on sns-103 targeting entpdase1 (cd39) at the american association for cancer research (aacr) annual meeting 2023

BOSTON, April 18, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and devel...

April 18, 2023, 8:05 pm

Panavance therapeutics announces positive preclinical data demonstrating gp-2250 single-agent and combination activity for the treatment of ovarian cancer

Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2023 GP-2250’s antineoplastic effects on ovarian cancer cells i...

April 17, 2023, 12:05 pm

2 growth stocks that jumped 42% and 58% last week: can they still climb higher?

The week that ended April 14 was a good one for markets overall and a great one for two stocks in the healthcare sector. Sana Biotechnology jumped 58%...

April 17, 2023, 6:17 am

Frontier medicines presents new preclinical data on its development candidate, fmc-376, a dual krasg12c inhibitor, at the 2023 aacr annual meeting

-FMC-376 is a highly selective, direct dual inhibitor designed to rapidly and completely block both the active and inactive forms of KRASG12C and over...

April 16, 2023, 7:00 pm

Context therapeutics says ctim-76 abstract accepted for presentation at aacr annual meeting, will host webinar

Context Therapeutics (NASDAQ:CNTX) Inc announced that an abstract regarding its preclinical candidate, ...

April 16, 2023, 3:01 am

Quanta therapeutics presents data from kras inhibitor pipeline at annual aacr meeting in late-breaking research session

– Data highlight favorable preclinical profiles for two chemically-distinct allosteric, oral small mo...

April 14, 2023, 4:05 pm

Molecular partners to present additional preclinical data supporting the company’s radio darpin therapy platform at aacr

Targeted radionuclide delivery platform strengthened by new safety and mechanistic data Data includes review of high tumor penetration potential of DA...

April 14, 2023, 5:00 am

Molecular partners to present additional preclinical data supporting the company's radio darpin therapy platform at aacr

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stag...

April 14, 2023, 1:00 am

Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by t...

April 12, 2023, 8:05 pm

Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by t...

April 12, 2023, 8:05 pm

Foghorn therapeutics to present preclinical data from its selective cbp and ep300 protein degrader programs and preclinical data for fhd-286, a potent, selective inhibitor of brg1 and brm, at the 2023

CAMBRIDGE, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a n...

April 10, 2023, 4:05 pm


Search within

Pages Search Results: